PROCEPT BioRobotics (PROCEPT BioRobotics) Cash-to-Debt : 2.77 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is PROCEPT BioRobotics Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. PROCEPT BioRobotics's cash to debt ratio for the quarter that ended in Mar. 2024 was 2.77.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, PROCEPT BioRobotics could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for PROCEPT BioRobotics's Cash-to-Debt or its related term are showing as below:

PRCT' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.81 Med: 3.08 Max: 5.9
Current: 2.77

During the past 5 years, PROCEPT BioRobotics's highest Cash to Debt Ratio was 5.90. The lowest was 1.81. And the median was 3.08.

PRCT's Cash-to-Debt is ranked better than
55.28% of 861 companies
in the Medical Devices & Instruments industry
Industry Median: 1.88 vs PRCT: 2.77

PROCEPT BioRobotics Cash-to-Debt Historical Data

The historical data trend for PROCEPT BioRobotics's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

PROCEPT BioRobotics Cash-to-Debt Chart

PROCEPT BioRobotics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

1.81

1.83

5.63

2.87

3.25

PROCEPT BioRobotics Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial												2.26	1.85	3.60	3.25	2.77

Competitive Comparison of PROCEPT BioRobotics's Cash-to-Debt

For the Medical Devices subindustry, PROCEPT BioRobotics's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PROCEPT BioRobotics's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PROCEPT BioRobotics's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where PROCEPT BioRobotics's Cash-to-Debt falls into.

PROCEPT BioRobotics Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

PROCEPT BioRobotics's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	257.222	/	(1.683	+	77.521)
	=	3.25

PROCEPT BioRobotics's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	225.576	/	(1.701	+	79.686)
	=	2.77

PROCEPT BioRobotics (NAS:PRCT) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

PROCEPT BioRobotics Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of PROCEPT BioRobotics's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

PROCEPT BioRobotics (PROCEPT BioRobotics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PROCEPT BioRobotics Corp (NAS:PRCT) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 Island Drive, Redwood, CA, USA, 94065

Website

https://www.procept-biorobotics.com

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.

Executives

Alaleh Nouri	officer: SVP, GEN COUNSEL, CORP. SEC.	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Kevin Waters	officer: Senior VP, CFO	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Frederic H Moll	director	C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
Wood Morgan Colby	director	C/O PROCEPT BIOROBOTICS CORPORATION, 900 ISLAND DRIVE, REDWOOD CA 94065
Reza Zadno	director, officer: President, CEO	2710 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Hisham Shiblaq	officer: SVP, Commercial Operations	C/O PROCEPT BIOROBOTICS CORPORATION, 900 ISLAND DRIVE, REDWOOD CITY CA 94065
Thomas M Krummel	director	C/O CALIFORNIA WATER SERVICE GROUP, 1720 N. FIRST STREET, SAN JOSE CA 95118
Viking Global Investors Lp	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
Viking Global Opportunities Parent Gp Llc	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
Dragsa 88 Llc	10 percent owner	55 RAILROAD AVE, GREENWICH CT 06830
Rose Sharon Shabet	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
Viking Global Opportunities Illiquid Investments Sub-master Lp	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
Viking Global Opportunities Gp Llc	10 percent owner	55 RAILROAD AVENUE, GREENWICH CT 06830
Viking Global Opportunities Portfolio Gp Llc	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901
David C. Ott	10 percent owner	600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901